Shining a light on infectious diseases management

Respiratory tract infections

Early, accurate pathogen identification—from laboratories to emergency care and point-of-care settings—is crucial to informing effective respiratory tract infection control.

Sexually transmitted infections

Curable infections like chlamydia, gonorrhea, and syphilis are estimated to affect more than 376 million people annually, while conditions like HIV face new management challenges with the potential overreliance on and limited adherence to pre-exposure treatments^2,3

Most infected individuals have few or no symptoms, making diagnostic testing critical to detect STIs and inform appropriate patient management⁴

Viral hepatitis

More than 300 million people are infected with the hepatitis B virus (HBV) or the hepatitis C virus (HCV) and 9 out of 10 people living with viral hepatitis are unaware.³ Access to high-quality testing and treatment monitoring are important for managing the burden of this disease.⁴

Congenital infections

During pregnancy, several pathogens can be vertically transmitted to a fetus or newborn which are linked to adverse pregnancy outcomes or consequences to the child.⁷

The newborn period is often the only point at which laboratory testing and follow-up allow confirmation of a congenital infection.⁸

Transfusion-transmitted infections

Blood and plasma donations are a selfless and life-saving gift, coming from over 118.5 million donations globally each year.⁷ Diagnostics is critical in maintaining a safe blood supply.

Transplant transmitted infections

An estimated 139,024 solid organ transplants are performed every year worldwide.⁸ Reliable diagnostic testing performed pre-or post-transplantation plays a key role in safeguarding the gift of life.

Vector-borne disease

Vector-borne diseases are caused by parasites, viruses and bacteria that are transmitted by vectors. They account for more than 17% of all infectious diseases and cause over 700K deaths annually.⁹ Diagnostics are critical for informing appropriate patient and disease management.

Healthcare associated infections (HAI)

7-10% of hospitalized patients in developing countries acquire HAIs, and it is the most frequent adverse event in health-care settings worldwide.

Molecular and serological diagnostic solutions are becoming critically important for the testing of hospital-acquired infections, particularly in the battle against antibiotic-resistant agents.

To complicate these infections, approximately 700,000 people die each year globally of antimicrobial-resistant infections – these types of infections are predicted to be a leading cause of death by 2050.¹¹

Gastrointestinal (GI) Infections

Gastrointestinal (GI) Infections cause a significant infectious disease burden worldwide. It is important to understand the cause and its prevalence.